. Thus, the variations in serum FT4 values in NTI seem to depend mostly on the assay methodology [10].
INDEXING TERMS: thyroid status . triiodothyronine
. hemodialysis#{149} immunoassay compared Nonthyroidal illness (NTI) is associated with many diverse effects on thyroid homeostasis.#{176} Serum concentrations of triiodothyronine (T3) are usually decreased, and thyrotropin (FSH) concentrations are usually within the reference range [1, 2] . Serum thyroxine (T.5) concentrations are often, though variably, affected in the low-T3 syndrome, whereas subsequently measured TSH concentrations are usually within the reference range but transiently slightly increased [3] . Thus, when assessing thyroid functions, the probability that the NTI is the cause of these findings is much greater than that of hypothyroidism.
Previous studies have shown that low serum concentrations of T3 are often but not always accompanied by increased concentrations of "reverse T3" (3,3', 5' -triiodothyronine) [4, 5] . In mild forms of NTI, serum concentrations of T4 and FT4 tend to be higher than normal, whereas moderate forms of NTI or caloric deprivation will produce normal or decreased concentrations of serum T4, with normal or high FL concentrations [as measured by equilibrium dialysis (ED)]; in critical illness, serum concentrations of T4 and FT4 are often low. Despite the low serum T4, however, FT4 concentrations determined by ED are normal, increased, or only slightly decreased [6, 7] . Most commercially available FT4 assay methods, which are not based on an ED methodology, measure low-normal or below-normal concentrations of FT4 in Nil [8, 9] . Thus, the variations in serum FT4 values in NTI seem to depend mostly on the assay methodology [10] .
The serum FT4 concentrationshave alsooften been shown to be low in patients with chronicrenalfailure (CRF) [7, 11, 12] . However, the serum FT4 concentrationsmeasured in such patients by ED/RIA are usually slightly higher than those measured by other methods, especially in patients undergoing chronic hemodialysis(HD). One reason forthisdifference may be the presence of heparin,which is administered to patients before dialysis [13] . Thus, we evaluatedthe serum Fr4 concen- III were collected from the three-way valve in the circular HD route within 2 mm after2000 IU of heparin was injected. All blood samples from groups II and IH were collected during routine examination.
Informed consent for evaluation of thyroid function was obtained from all subjects.
Clinical profiles of the CRF patients are given in Table 1 .
Groups H and Ill showed no differences of serum hemoglobin, total albumin, total cholesterol concentrations, or age, but their serum concentrations of urea nitrogen and creatinine differed significantly (P <0.01). Patients with positive (detectable) thyroid antibodies, e.g., antibodies to thyroid peroxidase or to thyroglobulmn, were excluded from the study. 
BIOCHEMICAL METHODS

Serum
Results
As shown in Table 2 , the serum FT4 concentrations measured by D-FT4 in either group II or III were significantly different from those in group I (P <0.01), whereas those measured by M-FT4 differed significantly between all groups (P <0.01), as shown in Fig. 1 (Fig. 3) . No effect on serum M-FT4 concentrations was seen at any of the four sampling times (Fig. 3) .
Dcuson Serum FT4 concentrations
have been shown to be low in patients with CRF [7, [19] [20] [21] . Our results also indicated that group II patients, 27% and 50% had FT4 concentrations below the normal reference range as measured by D-FT4 and M-FT4, respectively, compared with 32% and 86% of the group Ill patients.
Serum binding inhibitors such as furanic acid and 3-carboxy-4 methyl-5-propyl-2-furan propanoic acid in uremic patients, which could alter the FT4 fraction, may account for the divergent results between the two assays [22] . The additional albumin in the M-FT4 assay buffers, not included in the D-FT4 assay buffers, is capable of sequestering NEFA produced in vitro as well as other interfering substances already present in serum. This would result in lower FT4 in the M-FT4 assay than in the D-FT4 assay [17, 18] and would account for the difference in The serum FT4 concentrations measured by ED/RIA are usually slightly higher than those by other measurements, especially in patients undergoing chronic HD. Heparin is known to activate the lipoprotein lipases in blood, causing in vitro production of NEFAs that could entirely explain apparent increases in FT4 through their effects on bound T4 displacement [13, 23, 24] . A recent report has demonstrated that a low dose of intravenous heparin (5.6 IU) as well as a standard dose of subcutaneous heparin could cause in vitro generation of NEFA that would artifactually increase the FT4 concentrations measured by ED [25] . To investigate the effect of heparin, we measured FT4 by D-FT4 and M-FT4 and NEFA concentrations at four different times before and after injection of 2000 IU of heparin into patients on HD. Although the observed increase in NEFA concentrations in the relatively few samples measured 2 mm postheparin was not enough to be significantly different from the values in the preheparin group, this increase was accompanied by an equivalent very small nonsignificant increase in D-FT4 estimates. In some subjects, higher than usual concentrations of NEFA produced in vitro may partly account for the much wider range in D-FT4 concentrations postheparin, which is not seen in the M-FT4 results. Therefore, one must consider possible in vitro effects of heparin when evaluating the FT4 concentrations measured in group HI samples, even in samples drawn as soon as 2 mm after heparin injection.
Midgley et al. reported a significant correlation between the serum albumin concentration and the FT4 concentration measured by M-FT4 [26] . Because we found no correlation between serum albumin concentrations and the FT4 results, measurements in our assay were not influenced by albumin concentrations, even though the latter were greater than those studied in the other report [26] . However, serum FT4 concentrations were significantly inversely correlated with the serum creatinine concentrations, probably indicating that serum FT4 concentrations do reflect the severity of the disease as previously reported [21] .
Oxygen consumption and T3 nuclear binding have been reported to be higher in leukocytes from patients with NTI than in those from healthy controls [27] , as have higher concentrations of T3 receptor mRNA in liver [28] . Because the serum SHBG concentrations in groups II and III did not differ significantly from those in group I, we speculate that the thyroid hormone-protective function in tissues such as the liver is normal despite the low circulating concentrations of FT4.
In conclusion, our results indicate that the low FT4 values measured by D-FT4 in patients with CRF, particularly those undergoing chronic HD, may in part reflect the actual, mild nonthyroidal illness of renal failure. However, we need to consider the different distributions of FT4 results postheparin, which are not reflected in the preheparin distributions.
